NL8500724A - Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan. - Google Patents

Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan. Download PDF

Info

Publication number
NL8500724A
NL8500724A NL8500724A NL8500724A NL8500724A NL 8500724 A NL8500724 A NL 8500724A NL 8500724 A NL8500724 A NL 8500724A NL 8500724 A NL8500724 A NL 8500724A NL 8500724 A NL8500724 A NL 8500724A
Authority
NL
Netherlands
Prior art keywords
phase
limiting
cellulose
housing
granulate
Prior art date
Application number
NL8500724A
Other languages
English (en)
Dutch (nl)
Original Assignee
Univ Groningen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Groningen filed Critical Univ Groningen
Priority to NL8500724A priority Critical patent/NL8500724A/nl
Priority to DE8686200384T priority patent/DE3683385D1/de
Priority to EP86200384A priority patent/EP0196700B1/en
Priority to US06/838,248 priority patent/US4708874A/en
Priority to AT86200384T priority patent/ATE71521T1/de
Priority to CA000503919A priority patent/CA1265449A/en
Priority to DK114886A priority patent/DK170244B1/da
Priority to AU54651/86A priority patent/AU578577B2/en
Priority to JP61058020A priority patent/JPH0776171B2/ja
Publication of NL8500724A publication Critical patent/NL8500724A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8500724A 1985-03-13 1985-03-13 Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan. NL8500724A (nl)

Priority Applications (9)

Application Number Priority Date Filing Date Title
NL8500724A NL8500724A (nl) 1985-03-13 1985-03-13 Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
DE8686200384T DE3683385D1 (de) 1985-03-13 1986-03-10 Einrichtungen fuer die kontrollierte abgabe von aktiven substanzen und verfahren zu ihrer herstellung.
EP86200384A EP0196700B1 (en) 1985-03-13 1986-03-10 Devices for the controlled release of active substances, as well as process for the preparation thereof
US06/838,248 US4708874A (en) 1985-03-13 1986-03-10 Devices for the controlled release of active substances, as well as process for the preparation thereof
AT86200384T ATE71521T1 (de) 1985-03-13 1986-03-10 Einrichtungen fuer die kontrollierte abgabe von aktiven substanzen und verfahren zu ihrer herstellung.
CA000503919A CA1265449A (en) 1985-03-13 1986-03-12 Devices for the controlled release of active substances, as well as process for the preparation thereof
DK114886A DK170244B1 (da) 1985-03-13 1986-03-12 Indretning til kontrolleret afgivelse af aktive substanser samt fremgangsmåde til fremstilling af en sådan indretning
AU54651/86A AU578577B2 (en) 1985-03-13 1986-03-12 Devices for the controlled release of active substances, as well as process for the preparation thereof
JP61058020A JPH0776171B2 (ja) 1985-03-13 1986-03-13 １つ又はそれ以上の活性成分を液に調整放出する組成物及びその調整方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8500724 1985-03-13
NL8500724A NL8500724A (nl) 1985-03-13 1985-03-13 Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.

Publications (1)

Publication Number Publication Date
NL8500724A true NL8500724A (nl) 1986-10-01

Family

ID=19845674

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8500724A NL8500724A (nl) 1985-03-13 1985-03-13 Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.

Country Status (9)

Country Link
US (1) US4708874A (ja)
EP (1) EP0196700B1 (ja)
JP (1) JPH0776171B2 (ja)
AT (1) ATE71521T1 (ja)
AU (1) AU578577B2 (ja)
CA (1) CA1265449A (ja)
DE (1) DE3683385D1 (ja)
DK (1) DK170244B1 (ja)
NL (1) NL8500724A (ja)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507832A (en) * 1982-09-23 1985-04-02 Technology Consulting Corporation Method and apparatus for the continuous treatment of yarn
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
US4837032A (en) * 1986-02-04 1989-06-06 Farval Ag Theophylline sustained release tablet
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
US4970075A (en) * 1986-07-18 1990-11-13 Euroceltique, S.A. Controlled release bases for pharmaceuticals
NZ222698A (en) * 1987-01-08 1990-02-26 Squibb & Sons Inc Bioadhesive suppository formulations comprising a medicament, water, a hydrocolloid and low melting point base
US5015480A (en) * 1987-11-25 1991-05-14 Eli Lilly And Company Film coating formulations
JP2643222B2 (ja) * 1988-02-03 1997-08-20 エーザイ株式会社 多重層顆粒
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
US5002774A (en) * 1989-06-08 1991-03-26 Erbamont, Inc. Sustained release pharmaceutical tablet
DE4127665A1 (de) * 1991-08-22 1993-02-25 Beiersdorf Ag Galenische matrix
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
IL109460A (en) 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
KR950007873A (ko) * 1993-09-20 1995-04-15 후꾸하라 요시하루 생리 활성 물질 지속 방출형의 의약 제제
FR2718020B1 (fr) * 1994-04-01 1996-05-31 Biotec Centre Sa Composition galénique mucoadhésive hétérofonctionnelle.
AT403988B (de) * 1994-05-18 1998-07-27 Lannacher Heilmittel Festes orales retardpräparat
AU2540495A (en) * 1994-06-10 1996-01-05 Fernz Corporation Limited Biodegradable sustained release composition
US5744164A (en) * 1994-12-16 1998-04-28 Nestec S.A. Sustained release microparticulate caffeine formulation
DE29502547U1 (de) * 1995-02-16 1995-03-30 Röhm GmbH, 64293 Darmstadt Thermoplastisches Überzugs- und Bindemittel für Arzneiformen
US6083532A (en) 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
US6251430B1 (en) * 1998-02-04 2001-06-26 Guohua Zhang Water insoluble polymer based sustained release formulation
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
US20090149479A1 (en) * 1998-11-02 2009-06-11 Elan Pharma International Limited Dosing regimen
US20090297597A1 (en) * 1998-11-02 2009-12-03 Gary Liversidge Modified Release Ticlopidine Compositions
US20060240105A1 (en) * 1998-11-02 2006-10-26 Elan Corporation, Plc Multiparticulate modified release composition
PL205109B1 (pl) 1998-11-02 2010-03-31 Elan Pharma Int Ltd Wielocząstkowa kompozycja metylofenidatu o modyfikowanym uwalnianiu i jej zastosowanie
US20070122481A1 (en) * 1998-11-02 2007-05-31 Elan Corporation Plc Modified Release Compositions Comprising a Fluorocytidine Derivative for the Treatment of Cancer
US6340478B1 (en) * 1999-06-07 2002-01-22 Bio Dar Ltd. Microencapsulated and controlled-release herbal formulations
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
IL131508A (en) 1999-08-19 2006-12-10 David Cohen Micronexulatory formulations and controlled dispersion of isoflavins from rich masses of sesame and other plants
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
ATE526950T1 (de) * 1999-10-29 2011-10-15 Euro Celtique Sa Hydrocodon-formulierungen mit gesteuerter freisetzung
AT414205B (de) * 2000-06-20 2006-10-15 Vis Vitalis Lizenz & Handels Verfahren zur herstellung von ungesättigtem fettsäure-trockenkonzentrat
DE10031043A1 (de) 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
EP2263658A1 (en) 2000-10-30 2010-12-22 Euro-Celtique S.A. Controlled release hydrocodone formulations
UA81224C2 (uk) 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
KR20030060730A (ko) * 2002-01-09 2003-07-16 하나제약 주식회사 난용성 약물의 서방화 제제 조성물
HRP20020124A2 (en) * 2002-02-11 2003-10-31 Pliva D D Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
US20080220074A1 (en) * 2002-10-04 2008-09-11 Elan Corporation Plc Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
KR100540037B1 (ko) * 2003-06-27 2005-12-29 하나제약 주식회사 펠로디핀의 지속성 정제 및 그 제조방법
KR100914426B1 (ko) * 2004-08-06 2009-08-27 닛뽕소다 가부시키가이샤 용출 제어된 농약 제제
WO2006063078A2 (en) * 2004-12-08 2006-06-15 Elan Corporation, Plc Topiramate pharmaceuticals composition
AU2005320547B2 (en) 2004-12-27 2009-02-05 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
KR20070102563A (ko) * 2005-01-26 2007-10-18 엘란 파마 인터내셔널 리미티드 정신병치료제를 함유하는 조절방출형 조성물
US20070298098A1 (en) * 2005-02-16 2007-12-27 Elan Pharma International Limited Controlled Release Compositions Comprising Levetiracetam
AU2006235483B2 (en) * 2005-04-12 2010-11-25 Elan Pharma International Limited Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
US20070224233A1 (en) * 2005-08-05 2007-09-27 Nippon Soda Co., Ltd Controlled-Release Agricultural Chemical Formulation
PL1982590T3 (pl) * 2006-02-06 2017-11-30 Nippon Soda Co., Ltd. Zawierające pestycyd kompozycje żywiczne o kontrolowanym rozpuszczaniu, sposób ich wytwarzania i preparaty pestycydowe
US20070286903A1 (en) * 2006-06-13 2007-12-13 Becicka Brian T Composition and method for taste masking
CA2671200A1 (en) * 2006-07-21 2008-01-24 Lab International Srl Hydrophilic abuse deterrent delivery system
US8992898B2 (en) 2010-04-17 2015-03-31 Shannon Elizabeth Klingman Antiperspirants and deodorants
US20140179615A1 (en) * 2012-07-12 2014-06-26 Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd. Glutathione and Acetaminophen Composition and Preparation Method Thereof
HUE051406T2 (hu) 2012-11-14 2021-03-01 Grace W R & Co Biológiailag aktív anyagot és rendezetlen szervetlen oxidot tartalmazó kompozíciók
CA2936741C (en) 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10645931B2 (en) 2016-12-15 2020-05-12 Wellmark International Extended release formulation
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2793979A (en) * 1953-03-30 1957-05-28 Smith Kline French Lab Method of making a sustained release pharmaceutical tablet and product of the method
US2996431A (en) * 1953-12-16 1961-08-15 Barry Richard Henry Friable tablet and process for manufacturing same
US3166476A (en) * 1961-09-01 1965-01-19 Lowey Hans Powder based tablets
BE640616A (ja) * 1962-12-19
IE32806B1 (en) * 1968-05-21 1973-12-12 American Home Prod Sustained release drug composition
US3634584A (en) * 1969-02-13 1972-01-11 American Home Prod Sustained action dosage form
GB1405088A (en) * 1971-06-03 1975-09-03 Mundipharma Ag Slow release formulation
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
DE2426811A1 (de) * 1974-06-04 1976-01-08 Klinge Co Chem Pharm Fab Verfahren zur herstellung von retard-tabletten
US4139589A (en) * 1975-02-26 1979-02-13 Monique Beringer Process for the manufacture of a multi-zone tablet and tablet manufactured by this process
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
FR2403080A1 (fr) * 1977-09-15 1979-04-13 Heyden Chem Fab Preparation de nitrofurantoine a effet retard pour administration orale et son procede de fabrication
US4210139A (en) * 1979-01-17 1980-07-01 Alza Corporation Osmotic device with compartment for governing concentration of agent dispensed from device
JPS55153715A (en) * 1979-05-18 1980-11-29 Nikken Kagaku Kk Prolonged granule of theophylline
JPS5661311A (en) * 1979-10-25 1981-05-26 Fujisawa Pharmaceut Co Ltd Thial amide or prolonged pharmaceutical preparation comprising its salt
JPS56122311A (en) * 1980-02-29 1981-09-25 Eisai Co Ltd Lasting theophylline pharmaceutical composition
JPS5826816A (ja) * 1981-08-11 1983-02-17 Teisan Seiyaku Kk 球形顆粒からなる持続性複合顆粒剤
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
JPS5883613A (ja) * 1981-11-10 1983-05-19 Toa Eiyou Kagaku Kogyo Kk 硝酸イソソルビト−ル製剤
DE3218150C2 (de) * 1982-05-14 1986-09-25 Akzo Gmbh, 5600 Wuppertal Wirkstoff enthaltender Körper für die Langzeitabgabe sowie Verfahren zu dessen Herstellung
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation

Also Published As

Publication number Publication date
EP0196700A1 (en) 1986-10-08
US4708874A (en) 1987-11-24
CA1265449C (en) 1990-02-06
DE3683385D1 (de) 1992-02-27
AU578577B2 (en) 1988-10-27
JPS61251617A (ja) 1986-11-08
ATE71521T1 (de) 1992-02-15
CA1265449A (en) 1990-02-06
AU5465186A (en) 1986-09-18
DK170244B1 (da) 1995-07-17
DK114886A (da) 1986-09-14
EP0196700B1 (en) 1992-01-15
JPH0776171B2 (ja) 1995-08-16
DK114886D0 (da) 1986-03-12

Similar Documents

Publication Publication Date Title
NL8500724A (nl) Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
EP0235986B2 (en) Slow release formulation
EP0523847B1 (en) Taste mask coating for preparation of chewable pharmaceutical tablets
US4748023A (en) Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content
CA1324081C (en) Slow-release pharmaceutical agent
EP0194838A2 (en) Controlled-release pharmaceutical formulation
RU2101009C1 (ru) Твердая лекарственная форма для орального применения с замедленным высвобождением активного вещества и способ ее изготовления (варианты)
NZ201008A (en) Oral preparations containing dipyridamole and at least 5 molar equivalents of orally acceptable acidic excipient
JPH0122245B2 (ja)
NL8500856A (nl) Bij opslag stabiele, snel uiteenvallende geperste voortbrengsels van een farmaceutisch werkzame stof alsmede een werkwijze ter vervaardiging ervan.
CZ20023379A3 (cs) Farmaceutické kompozice obsahující fluvastatin a hydroxypropylmethylcelulózu a způsoby prevence tvorby gelů hydratované hydroxypropylmethylcelulózy v těchto kompozicích
NL8601961A (nl) Granulaire vorm van farmaceutisch werkzame stoffen met vertraagde afgifte.
FI96095C (fi) Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi
JPH02104A (ja) 薬物放出速度調節型製剤
US6132772A (en) Extended-release solid oral dosage forms of drugs having low solubility in water
KR970007899B1 (ko) 맛 은폐를 위한 수단을 포함하는 저작가능한 의약 정제
US3632778A (en) Tablets containing l-dopa
US3453360A (en) Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
JPS63165318A (ja) 光の影響に対して安定化したニフェディピン濃縮物及びその製造方法
US7364755B2 (en) Modified calcium phosphate excipient
CA2658512A1 (en) Orally dissolvable/disintegrable lyophilized dosage forms containing protected particles
US4601895A (en) Delayed-action acetylsalicylic acid formulations for oral administration
JPH03500288A (ja) 徐放性ニフェジピン製剤
EP0425298B1 (en) Sustained-release preparation of basic medical agent hydrochloride
US5879714A (en) Controlled-release pharmaceutical compositions

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BV The patent application has lapsed